According to Zhitong Finance App News, Jindick (688670.SH) released its 2023 annual report. During the reporting period, the company achieved operating income of 135 million yuan, a year-on-year decrease of 57.74%; net loss attributable to shareholders of listed companies was 72.503 million yuan, which changed from profit to loss; net loss attributable to shareholders of listed companies was deducted from non-recurring profit and loss of 72.579 million yuan, year-on-year from profit to loss; basic loss per share was 0.58 yuan/share.
During the reporting period, operating revenue decreased by 57.74% compared to the same period last year. The main reason was that production was temporarily suspended due to a sudden heavy rain in Taizhou, where the company is located in July 2023, and influenza vaccine sales resumed until December 18, 2023, which led to a decline in the company's sales revenue during the 2023 influenza vaccine sales season.
